Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 40 results.
User Information
Export Records
  1. 1.   Anti-drug Antibody Responses Impair Prophylaxis Mediated by AAV-Delivered HIV-1 Broadly Neutralizing Antibodies
  2. Gardner, Matthew R.; Fetzer, Ina; Kattenhorn, Lisa M.; Davis-Gardner, Meredith E.; Zhou, Amber S.; Alfant, Barnett; Weber, Jesse A.; Kondur, Hema R.; Martinez-Navio, Jose M.; Fuchs, Sebastian P.; Desrosiers, Ronald C.; Gao, Guangping; Lifson,Jeffrey; Farzan, Michael
  3. Molecular therapy : the journal of the American Society of Gene Therapy. 2019, Mar 6; 27(3): 650-660.
  1. 2.   IL-15/IL-15R alpha/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice
  2. Shi, Yimin; Dincheva-Vogel, Lillie; Ayemoba, Charles E.; Fung, Jeffrey P.; Bergamaschi, Cristina; Pavlakis, George; Farzaneh, Farzin; Gaensler, Karin M. L.
  3. BLOOD ADVANCES. 2018, NOV 27; 2(22): 3177-3192.
  1. 3.   The Role of Estrogen Receptor alpha and beta in Regulating Vascular Smooth Muscle Cell Proliferation is Based on Sex
  2. Hogg, M. E.; Vavra, A. K.; Banerjee, M. N.; Martinez, J.; Jiang, Q.; Keefer, L. K.; Chambon, P.; Kibbe, M. R.
  3. Journal of Surgical Research. 2012, Mar; 173(1): E1-E10.
  1. 4.   IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
  2. Kerkar, S. P.; Goldszmid, R. S.; Muranski, P.; Chinnasamy, D.; Yu, Z. Y.; Reger, R. N.; Leonardi, A. J.; Morgan, R. A.; Wang, E.; Marincola, F. M.; Trinchieri, G.; Rosenberg, S. A.; Restifo, N. P.
  3. Journal of Clinical Investigation. 2011, Dec; 121(12): 4746-4757.
  1. 5.   Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques
  2. Kulkarni, V.; Jalah, R.; Ganneru, B.; Bergamaschi, C.; Alicea, C.; von Gegerfelt, A.; Patel, V.; Zhang, G. M.; Chowdhury, B.; Broderick, K. E.; Sardesai, N. Y.; Valentin, A.; Rosati, M.; Felber, B. K.; Pavlakis, G. N.
  3. Vaccine. 2011, Sep; 29(39): 6742-6754.
  1. 6.   A New Generation of Serotype Chimeric Infectivity-Enhanced Conditionally Replicative Adenovirals: The Safety Profile of Ad5/3-Delta 24 in Advance of a Phase I Clinical Trial in Ovarian Cancer Patients
  2. Kim, K. H.; Ryan, M. J.; Estep, J. E.; Miniard, B. M.; Rudge, T. L.; Peggins, J. O.; Broadt, T. L.; Wang, M. H.; Preuss, M. A.; Siegal, G. P.; Hemminki, A.; Harris, R. D.; Aurigemma, R.; Curiel, D. T.; Alvarez, R. D.
  3. Human Gene Therapy. 2011, Jul; 22(7): 821-828.
  1. 7.   Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes
  2. Varu, V. N.; Ahanchi, S. S.; Hogg, M. E.; Bhikhapurwala, H. A.; Chen, A.; Popowich, D. A.; Vavra, A. K.; Martinez, J.; Jiang, Q.; Saavedra, J. E.; Hrabie, J. A.; Keefer, L. K.; Kibbe, M. R.
  3. American Journal of Physiology-Heart and Circulatory Physiology. 2010, Sep; 299(3): H772-H779.
  1. 8.   Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization
  2. Patel, V.; Valentin, A.; Kulkarni, V.; Rosati, M.; Bergamaschi, C.; Jalah, R.; Alicea, C.; Minang, J. T.; Trivett, M. T.; Ohlen, C.; Zhao, J.; Robert-Guroff, M.; Khan, A. S.; Draghia-Akli, R.; Felber, B. K.; Pavlakis, G. N.
  3. Vaccine. 2010, Jul; 28(30): 4827-4836.
  1. 9.   Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury
  2. Tsihlis, N. D.; Murar, J.; Kapadia, M. R.; Ahanchi, S. S.; Oustwani, C. S.; Saavedra, J. E.; Keefer, L. K.; Kibbe, M. R.
  3. Journal of Vascular Surgery. 2010, May; 51(5): 1248-1259.
  1. 10.   Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit
  2. Valentin, A.; von Gegerfelt, A.; Rosati, M.; Miteloudis, G.; Alicea, C.; Bergamaschi, C.; Jalah, R.; Patel, V.; Khan, A. S.; Draghia-Akli, R.; Pavlakis, G. N.; Felber, B. K.
  3. Vaccine. 2010, Feb; 28(8): 1962-1974.
  1. 11.   In vivo expression of signaling proteins in reconstituted NK cells
  2. Orr, S. J.; Quigley, L.; McVicar, D. W.
  3. Journal of Immunological Methods. 2009 340(2): 158-163.
  1. 12.   Nitric oxide and nanotechnology: A novel approach to inhibit neointimal hyperplasia
  2. Kapadia, M. R.; Chow, L. W.; Tsihlis, N. D.; Ahanchi, S. S.; Hrabie, J. A.; Murar, J.; Martinez, J.; Popowich, D. A.; Jiang, Q.; Hrabie, J. A.; Saavedra, J. E.; Keefer, L. K.; HUlvat, J. F.; Stupp, S. I.; Kibbe, M. P.
  3. Journal of Vascular Surgery. 2008 47(1): 173-182.
  1. 13.   Transduction of rhesus macaque hematopoietic stem and progenitor cells with avian sarcoma and leukosis viral vectors
  2. Hu, J. Q.; Ferris, A.; Larochelle, A.; Krouse, A. E.; Metzger, M. E.; Donahue, R. E.; Hughes, S. H.; Dunbar, C. E.
  3. Human Gene Therapy. 2007, Aug; 18(8): 691-700.
  1. 14.   Potential of transfected muscle cells to contribute to DNA vaccine immunogenicity
  2. Shirota, H.; Petrenko, L.; Hong, C.; Klinman, D. M.
  3. Journal of Immunology. 2007, Jul; 179(1): 329-336.
  1. 15.   Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques
  2. Luckay, A.; Sidhu, M. K.; Kjeken, R.; Megati, S.; Chong, S. Y.; Roopch, V.; Garcia-H, D.; Abdullah, R.; Braun, R.; Montefiori, D. C.; Rosati, M.; Felber, B. K.; Pavlakis, G. N.; Mathiesen, I.; Israel, Z. R.; Eldridge, J. H.; Egan, M. A.
  3. Journal of Virology. 2007, May; 81(10): 5257-5269.
  1. 16.   De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses
  2. Wang, D. H.; Schmaljohn, A. L.; Raja, N. U.; Trubey, C. M.; Juompan, L. Y.; Luo, M.; Deitz, S. B.; Yu, H.; Woraratanadharm, J.; Holman, D. H.; Moore, K. M.; Swain, B. M.; Pratt, W. D.; Dong, J. Y.
  3. Vaccine. 2006, Apr; 24(15): 2975-2986.
  1. 17.   Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag
  2. Rulli, S. J.; Muriaux, D.; Nagashima, K.; Mirro, J.; Oshima, M.; Baumann, J. G.; Rein, A.
  3. Virology. 2006, Apr; 347(2): 364-371.
  1. 18.   Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR
  2. Boyd, K. E.; Xiao, Y. Y.; Fan, K.; Poholek, A.; Copeland, N. G.; Jenkins, N. A.; Perkins, A. S.
  3. Blood. 2006, JAN 15; 107(2): 733-741.
  1. 19.   Retroviral transduction of IL-7R alpha into IL-7R alpha(-/-) bone marrow progenitors: correction of lymphoid deficiency and induction of neutrophilia
  2. Jiang, Q.; Li, W. Q.; Aiello, F. B.; Klarmann, K.; Keller, J. R.; Durum, S. K.
  3. Gene Therapy. 2005, DEC; 12(24): 1761-1768.
  1. 20.   Ex vivo expanded murine bone marrow cells with a multiple cytokine cocktail retain long-term hematopoietic reconstitution potentials
  2. Yang, Q. E.; Fong, S. E.; Li, K. G.; Gonda, M. A.; Tobin, G. J.
  3. Medical Science Monitor. 2005, JUN; 11(6): BR154-BR161.
  1. 21.   Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice
  2. Kim, H. W.; Park, I. K.; Cho, C. S.; Lee, K. H.; Beck, G. R.; Colburn, N. H.; Cho, M. H.
  3. Cancer Research. 2004, NOV 1; 64(21): 7971-7976.
  1. 22.   Cancer-specific ligands identified from screening of peptide-display libraries
  2. Mori, T.
  3. Current Pharmaceutical Design. 2004 10(19): 2335-2343.
  1. 23.   Identification of PDGFR as a receptor for AAV-5 transduction
  2. Di Pasquale, G.; Davidson, B. L.; Stein, C. S.; Martins, I. S.; Scudiero, D.; Monks, A.; Chiorini, J. A.
  3. Nature Medicine. 2003 9(10): 1306-1312.
  1. 24.   Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice
  2. Sun, M. S.; Pan, C. J.; Shieh, J. J.; Ghosh, A.; Chen, L. Y.; Mansfield, B. C.; Ward, J. M.; Byrne, B. J.; Chou, J. Y.
  3. Human Molecular Genetics. 2002 11(18): 2155-2164.
  1. 25.   Thresholds of O-6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide
  2. Kokkinakis, D. M.; Bocangel, D. B.; Schold, S. C.; Moschel, R. C.; Pegg, A. E.
  3. Clinical Cancer Research. 2001 7(2): 421-428.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel